MicroRNA‑150‑5p and SRC kinase signaling inhibitor 1 involvement in the pathological development of gastric cancerXiyun Quan(Zhuzhou Central Hospital), Meiyuan Huang(Zhuzhou Central Hospital)Experimental and Therapeutic MedicineJuly 30, 201910.3892/etm.2019.7828Cited by 13SaveCiteExport RISWatch citationsRelated PapersAdditional file 4: of Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma|Figshare|2018|0